Abstract
ObjectivesTo determine whether patients with early rheumatoid arthritis (ERA) have cardiovascular disease (CVD) that is modifiable with disease-modifying antirheumatic drug (DMARD) therapy, comparing first-line etanercept (ETN) + methotrexate (MTX) with...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have